fbpx
Connect with us

News

UK company launches genetically-personalised supplements

Published

on

A London-based supplement company has launched a new tool aimed at developing genetically-personalised sport and health supplements.

Wiley Nutrition’s proprietary algorithm and decision tool uses genomic sequencing, blood-testing and qualitative/quantitative survey metrics.

The patent-pending technology detects how variants in the genome may impact an individual’s propensity for nutritional deficiencies and predisposition to injury.

The solution is powered by nutrigenomics – the study of the effects of food and food constituents on gene expression, and how genetic variations affect the nutritional environment.

It focuses on understanding the interaction between nutrients and other dietary bioactives with the genome at the molecular level, to understand how specific nutrients or dietary regimes may affect human health.

The company hopes to provide an alternative to the existing market for nutritional supplements which is dominated by ‘one size fits all’ products.

Theo Wiley, founder & CEO at Wiley Nutrition, said:

“We are officially disrupting the sports nutrition industry.

“Our revolutionary platform takes data sets that are specific to you, (genetics, blood serum, individualised surveys) and spits out a custom health insights report and personalised supplement that is exactly aligned to your biology.

“The old paradigm of taking an under-dosed, over-priced supplement packed full of hidden and potentially dangerous ingredients is no more.

“The world has moved onto precision medicine and we are the consumer equivalent of that – using clinical data to support nutritional intake.”

Having launched their beta-testing program, Wiley Nutrition is partnered with US genetic sequencing provider, Nebula Genomics.

The company is now seeking funding for its pre-seed round following successful completion of the Foundersboost (formerly Start-Up Boost) accelerator programme.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories